Literature DB >> 15004750

Association between IFNA genotype and the risk of sarcoidosis.

Mitsuteru Akahoshi1, Mami Ishihara, Natascha Remus, Kazuko Uno, Katsuhisa Miyake, Tomomitsu Hirota, Kazuko Nakashima, Akira Matsuda, Mizuo Kanda, Tadao Enomoto, Shigeaki Ohno, Hitoshi Nakashima, Jean-Laurent Casanova, Julian M Hopkin, Mayumi Tamari, Xiao-Quan Mao, Taro Shirakawa.   

Abstract

Sarcoidosis is known to be a systemic granulomatous disorder characterized by a cell-mediated Th1-type inflammatory response. To identify a key genetic factor in the pathogenesis of sarcoidosis, we investigated single nucleotide polymorphisms within 10 candidate genes involved in type 1 immune process ( IFNA17, IFNB, IFNG, IFNGR1, IFNGR2, IL12B, IL12RB1, IL12RB2, ETA-1, and NRAMP1) in an association-based study of 102 Japanese patients with sarcoidosis, 114 with tuberculosis, and 110 control subjects. After correction for multiple testing, an IFNA17 polymorphism (551T-->G) was found to be associated with susceptibility to sarcoidosis (odds ratio 3.27 [95% CI: 1.44-7.46], P=0.004, P(c)=0.04), but not to tuberculosis. We observed no significant associations with the other polymorphisms of the Th1-related genes. We further typed another IFNA polymorphism ( IFNA10 60T-->A) and confirmed two major haplotypes of the IFNA gene, viz., allele 1: IFNA10 [60T]- IFNA17 [551T] and allele 2: IFNA10 [60A]- IFNA17 [551G], in the Japanese population. In healthy subjects, IFNA allele 2, which is over-represented in patients with sarcoidosis, was significantly associated with increased IFN-alpha and IL-12p70 production induced by Sendai virus in vitro. This study suggests that possession of the IFNA allele with higher levels of IFN-alpha significantly increases the risk of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004750     DOI: 10.1007/s00439-004-1099-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  28 in total

Review 1.  Type I interferons and T helper development.

Authors:  J D Farrar; K M Murphy
Journal:  Immunol Today       Date:  2000-10

Review 2.  Nomination of a candidate susceptibility gene in sarcoidosis: the complement receptor 1 gene.

Authors:  Michael C Iannuzzi; Mary Maliarik; Benjamin A Rybicki
Journal:  Am J Respir Cell Mol Biol       Date:  2002-07       Impact factor: 6.914

3.  Polymorphism of Clara cell 10-kD protein gene of sarcoidosis.

Authors:  Takashi Ohchi; Noriharu Shijubo; Isao Kawabata; Shingo Ichimiya; Shin-ichiro Inomata; Akihiro Yamaguchi; Yoshifumi Umemori; Yoshihisa Itoh; Shosaku Abe; Yomei Hiraga; Noriyuki Sato
Journal:  Am J Respir Crit Care Med       Date:  2003-10-09       Impact factor: 21.405

4.  Determination of interferon-alpha-producing capacity in whole blood cultures from patients with various diseases and from healthy persons.

Authors:  K Uno; K Nakano; N Maruo; H Onodera; H Mata; I Kurosu; K Akatani; N Ikegami; A Kishi; Y Yasuda; K Tanaka; J Setoguchi; M Kondo; S Muramatsu; T Kishida
Journal:  J Interferon Cytokine Res       Date:  1996-11       Impact factor: 2.607

Review 5.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

6.  The interferon gene cluster: a candidate region for MS predisposition? Multiple Sclerosis Study Group.

Authors:  B Miterski; S Jaeckel; J T Epplen; D Pöhlau; C Hardt
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

Review 7.  Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

8.  Genetic predisposition to multiple sclerosis as revealed by immunoprinting.

Authors:  C Epplen; S Jäckel; E J Santos; M D'Souza; D Poehlau; B Dotzauer; E Sindern; M Haupts; K P Rüde; F Weber; J Stöver; S Poser; W Gehler; J P Malin; H Przuntek; J T Epplen
Journal:  Ann Neurol       Date:  1997-03       Impact factor: 10.422

9.  Polymorphism in the interferon-alpha gene family.

Authors:  I Golovleva; M Kandefer-Szerszen; L Beckman; E Lundgren
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

10.  Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis.

Authors:  C M Greene; G Meachery; C C Taggart; C P Rooney; R Coakley; S J O'Neill; N G McElvaney
Journal:  J Immunol       Date:  2000-10-15       Impact factor: 5.422

View more
  25 in total

Review 1.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  Impairment of IFN-alpha production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma.

Authors:  Kazuko Uno; Yoshiki Suginoshita; Kazuhiro Kakimi; Fuminori Moriyasu; Mayumi Hirosaki; Taro Shirakawa; Tsunataro Kishida
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 3.  Genetic predisposition to respiratory diseases: infiltrative lung diseases.

Authors:  Mark P Steele; Kevin K Brown
Journal:  Respiration       Date:  2007       Impact factor: 3.580

4.  Familial sarcoidosis: Report of a mother and her son.

Authors:  Ekin Akyıldız; Şenol Kobak
Journal:  Eur J Rheumatol       Date:  2017-10-25

5.  Interferon-alpha Induced Sarcoidosis with Cutaneous Involvement along the Lines of Venous Drainage.

Authors:  Young Bok Lee; Jae In Lee; Hyun Jeong Park; Baik Kee Cho; Shin Taek Oh
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

Review 6.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

7.  Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis.

Authors:  Elliott D Crouser; Daniel A Culver; Kenneth S Knox; Mark W Julian; Guohong Shao; Susamma Abraham; Sandya Liyanarachchi; Jennifer E Macre; Mark D Wewers; Mikhail A Gavrilin; Patrick Ross; Abbas Abbas; Charis Eng
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

8.  Analysis of eight genes modulating interferon gamma and human genetic susceptibility to tuberculosis: a case-control association study.

Authors:  Marlo Möller; Almut Nebel; Paul D van Helden; Stefan Schreiber; Eileen G Hoal
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

Review 9.  Identifying Novel Biomarkers in Sarcoidosis Using Genome-Based Approaches.

Authors:  Nancy Casanova; Tong Zhou; Kenneth S Knox; Joe G N Garcia
Journal:  Clin Chest Med       Date:  2015-09-26       Impact factor: 2.878

Review 10.  Dendritic cells in the pathogenesis of sarcoidosis.

Authors:  Lisa C Zaba; Gideon P Smith; Miguel Sanchez; Stephen D Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.